The Cancer-Testis Gene, NY-ESO-1, Is Expressed in Normal Fetal and Adult Testes and in Spermatocytic Seminomas and Testicular Carcinoma In Situ
Open Access
- 1 June 2002
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (6) , 775-780
- https://doi.org/10.1097/01.lab.0000017169.26718.5f
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumorsCancer, 2001
- NY-ESO-1 and CTp11 Expression May Correlate with Stage of Progression in MelanomaJournal of Surgical Research, 2001
- Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissuesInternational Journal of Cancer, 2001
- Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancersProceedings of the National Academy of Sciences, 2000
- NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimensBritish Journal of Cancer, 2000
- Testicular cancer in nine northern european countriesInternational Journal of Cancer, 1994
- Clues to the Aetiology of Testicular Germ Cell Tumours from Descriptive EpidemiologyEuropean Urology, 1993
- Placental‐like alkaline phosphatase as a marker of carcinoma‐in‐situ of the testis. Comparison with monoclonal antibodies M2A and 43–9FAPMIS, 1991
- Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982British Journal of Cancer, 1986
- Risk factors for cancer of the testis in young menInternational Journal of Cancer, 1979